Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of spironolactone on collagen markers
in a large number of patients with pulmonary hypertension. In addition, safety and
tolerability of spironolactone, an aldosterone receptor antagonist, in patients with
pulmonary arterial hypertension, will be determined.